Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 Biomarker disease BEFREE Friedreich ataxia (FRDA) is a multisystem neurodegenerative disorder and the most common hereditary ataxia. 31575456 2019
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 GeneticVariation disease BEFREE Friedreich's ataxia (FRDA; OMIM 229300), an autosomal recessive neurodegenerative mitochondrial disease, is the most prevalent hereditary ataxia. 29509186 2018
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 GeneticVariation disease BEFREE Although ataxia can be a symptom of many common conditions, the focus here is on the progressive ataxias, and include hereditary ataxia (e.g. spinocerebellar ataxia (SCA), Friedreich's ataxia (FRDA)), idiopathic sporadic cerebellar ataxia, and specific neurodegenerative disorders in which ataxia is the dominant symptom (e.g. cerebellar variant of multiple systems atrophy (MSA-C)). 30786918 2019
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 Biomarker disease BEFREE Friedreich ataxia is the most common of the hereditary ataxias. 31494282 2019
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 Biomarker disease BEFREE Nerve conduction studies have been performed in 19 subject with hereditary spinocerebellar degenerations other than Friedreich ataxia. 7231446 1981
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.360 GeneticVariation disease BEFREE The GAA trinucleotide repeats in the FXN gene were analyzed by triplet repeat-primed PCR (TP-PCR) in 122 unrelated hereditary ataxia (HA) and 114 unrelated hereditary spastic paraplegia (HSP) patients. 25765228 2015
Entrez Id: 7274
Gene Symbol: TTPA
TTPA
0.300 Biomarker disease GENOMICS_ENGLAND Complexity of vitamin E metabolism. 26981194 2016
Entrez Id: 64374
Gene Symbol: SIL1
SIL1
0.300 Biomarker disease CTD_human
Entrez Id: 1200
Gene Symbol: TPP1
TPP1
0.300 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Entrez Id: 23064
Gene Symbol: SETX
SETX
0.300 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Entrez Id: 6513
Gene Symbol: SLC2A1
SLC2A1
0.300 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Entrez Id: 26090
Gene Symbol: ABHD12
ABHD12
0.300 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Entrez Id: 7466
Gene Symbol: WFS1
WFS1
0.300 Biomarker disease GENOMICS_ENGLAND Correction: Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. 30171196 2018
Entrez Id: 57410
Gene Symbol: SCYL1
SCYL1
0.200 Biomarker disease MGD
Entrez Id: 81790
Gene Symbol: RNF170
RNF170
0.200 Biomarker disease MGD
Entrez Id: 26278
Gene Symbol: SACS
SACS
0.100 GeneticVariation disease CLINVAR Novel mutations in the sacsin gene in ataxia patients from Maritime Canada. 19892370 2010
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.030 Biomarker disease BEFREE The objective of this study was to determine the prevalence of hereditary ataxias in Cuba, with a special focus on the clinical and molecular features of SCA2. 19429075 2009
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.030 GeneticVariation disease BEFREE Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. 10746559 2000
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.030 GeneticVariation disease BEFREE Changes in a long list of additional genes have been suggested as causes for parkinsonism or PD, including genes for hereditary ataxias (ATXN2, ATXN3, FMR1), frontotemporal dementia (C9ORF72, GRN, MAPT, TARDBP), DYT5 (GCH1, TH, SPR), and others (ATP13A2, CSF1R, DNAJC6, FBXO, GIGYF2, HTRA2, PLA2G6, POLG, SPG11, UCHL1). 23462481 2013
Entrez Id: 4061
Gene Symbol: LY6E
LY6E
0.020 GeneticVariation disease BEFREE Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. 10746559 2000
Entrez Id: 4061
Gene Symbol: LY6E
LY6E
0.020 Biomarker disease BEFREE The objective of this study was to determine the prevalence of hereditary ataxias in Cuba, with a special focus on the clinical and molecular features of SCA2. 19429075 2009
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.010 Biomarker disease BEFREE Serum FGF21 can be applied as the first molecular screening among patients suspected to be victims of hereditary ataxia with neuromuscular degeneration prior to mass genetic screening. 23031666 2012
Entrez Id: 23114
Gene Symbol: NFASC
NFASC
0.010 GeneticVariation disease BEFREE The identification of NFASC mutations paves the way for genetic research in the developing field of nodopathies, an emerging pathological entity involving the nodes of Ranvier, which are associated for the first time with a hereditary ataxia syndrome with neuropathy. 30850329 2019
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.010 GeneticVariation disease BEFREE Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. 20208537 2010